CPRT Quantitative Stock Analysis

Validea's 'Patient Investor' model, based on Warren Buffett's strategy, assigned COPART INC (CPRT) a 72% rating, which falls below the 80% threshold indicating 'some interest.' While the large-cap growth stock passed most of the model's criteria for long-term profitability and low debt, including earnings predictability and free cash flow, it notably failed on its use of retained earnings and initial rate of return, preventing a higher conviction score from the strategy.

Analysis

Copart Inc. (CPRT) presents a fundamentally sound but potentially overvalued profile based on Validea's 'Patient Investor' model, which emulates Warren Buffett's strategy. The company scored 72%, a respectable figure that nonetheless falls below the 80% threshold indicating active interest from the model. CPRT's strengths are rooted in its operational quality, passing key tests for earnings predictability, debt service, return on equity, return on total capital, and free cash flow. Furthermore, its share repurchase activity meets the strategy's criteria. However, the investment case is tempered by two significant failures: 'Use of Retained Earnings' and 'Initial Rate of Return.' The failure on retained earnings suggests potential inefficiencies in capital allocation for generating shareholder value, while the failure on initial rate of return indicates that the stock's current valuation may not provide the margin of safety or prospective returns demanded by a strict value-oriented approach.

Key Decisions for Investors

• The positive scores on core fundamentals like earnings predictability and low debt suggest that existing investors may find justification to hold their positions, as the underlying business appears robust.
• Potential value-oriented investors should exercise caution, as the model's failure on 'Initial Rate of Return' signals that CPRT's current market price may not offer an attractive entry point.
• Investors should conduct deeper due diligence on management's capital allocation strategy to understand why the company failed the 'Use of Retained Earnings' metric, as this could be a long-term drag on shareholder returns.